Congress Wealth Management LLC DE Sells 14 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Congress Wealth Management LLC DE decreased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 177 shares of the medical instruments supplier’s stock after selling 14 shares during the period. Congress Wealth Management LLC DE’s holdings in Mettler-Toledo International were worth $218,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Townsquare Capital LLC boosted its stake in Mettler-Toledo International by 2.0% during the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after buying an additional 9 shares during the period. Glenmede Trust Co. NA lifted its holdings in shares of Mettler-Toledo International by 2.2% in the 3rd quarter. Glenmede Trust Co. NA now owns 1,155 shares of the medical instruments supplier’s stock worth $1,732,000 after acquiring an additional 25 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Mettler-Toledo International by 4.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,989 shares of the medical instruments supplier’s stock worth $8,982,000 after purchasing an additional 234 shares during the period. Public Sector Pension Investment Board grew its holdings in Mettler-Toledo International by 12.3% during the 3rd quarter. Public Sector Pension Investment Board now owns 915 shares of the medical instruments supplier’s stock valued at $1,372,000 after purchasing an additional 100 shares during the last quarter. Finally, Edgestream Partners L.P. raised its position in Mettler-Toledo International by 1,270.6% in the 3rd quarter. Edgestream Partners L.P. now owns 3,262 shares of the medical instruments supplier’s stock worth $4,892,000 after purchasing an additional 3,024 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Citigroup reduced their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Evercore ISI lifted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. Finally, Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $1,380.50.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,176.04 on Monday. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The company has a market capitalization of $24.51 billion, a price-to-earnings ratio of 29.02, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. The company’s 50-day simple moving average is $1,283.84 and its two-hundred day simple moving average is $1,302.91.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 790 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.